- Evotec Shares Surge on $2.11 Billion Buyout Offer🔍
- Evotec shares surge 20% on Halozyme's 2 billion euro takeover bid🔍
- Possible takeover battle boosts Evotec share price🔍
- Large Pharma Partner Halozyme Therapeutics Offers To Acquire ...🔍
- Evotec soars 18% on 2 bln euro buyout offer🔍
- Europe's STOXX 600 falls as tech🔍
- Evotec surges on Halozyme takeover interest🔍
- Halozyme Therapeutics Inc. Stock Quote 🔍
Evotec Shares Surge on $2.11 Billion Buyout Offer
Evotec Shares Surge on $2.11 Billion Buyout Offer - MarketWatch
Shares in Evotec rose after the company said Thursday that it received a takeover offer from U.S. biotechnology company Halozyme Therapeutics ...
Evotec shares surge 20% on Halozyme's 2 billion euro takeover bid
The proposed acquisition involves Halozyme offering 11 euros per share for Evotec, representing a 27.5% premium to the company's most recent ...
Possible takeover battle boosts Evotec share price - MarketScreener
The US biotech company Halozyme Therapeutics wants to buy the Hamburg-based company for 11 euros per share in cash or 2 billion euros, as it ...
Large Pharma Partner Halozyme Therapeutics Offers To Acquire ...
Halozyme proposes €11.00/share cash acquisition of Evotec, valuing it at €2.0B, a 109% premium to October 15, 2024, price. · Proposed merger ...
Evotec soars 18% on 2 bln euro buyout offer - TradingView
Shares in Evotec XETR:EVT jump around 18% after biotech company Halozyme NASDAQ:HALO made a 2 billion euro ($2.11 billion) buyout offer for ...
Europe's STOXX 600 falls as tech, healthcare shares drag - Reuters
Among individual stocks, Evotec (EVTG.DE) , opens new tab jumped close to 20% after Halozyme Therapeutics (HALO.O) , opens new tab said it has ...
Evotec shares surge 20% on Halozyme's 2 billion euro takeover bid
Investing.com -- Halozyme Therapeutics (NASDAQ:HALO) announced on Thursday its plans to acquire German drug developer Evotec SE ADR (NASDAQ:EVO) in a deal ...
Evotec surges on Halozyme takeover interest - Sharecast.com
... Halozyme Therapeutics confirmed it had submitted a non-binding proposal to buy the German biotech for €11.00 per share in cash, or about €2bn.
Evotec soars 18% on 2 bln euro buyout offer - XM
... ($2.11 billion) buyout offer forthe German drug development company. ** ... ** Halozyme saidit intends to buy all shares of Evotec at 11 euros ...
Halozyme Therapeutics Inc. Stock Quote (U.S.: Nasdaq) | MarketWatch
Evotec Shares Surge on $2.11 Billion Buyout Offer. Nov. 15, 2024 at 3:56 a.m. ET. Halozyme Therapeutics Bids to Acquire German Competitor Evotec. Nov. 14, 2024 ...
Halozyme makes 2 billion euro buyout offer for drug developer Evotec
Halozyme intends to purchase all the shares of Evotec at 11 euros per share, which represents a premium of 27.5% to Evotec's last close ...
European Stocks Struggle as Technology and Healthcare Shares ...
Evotec Soars Amid Acquisition Proposal. Despite the overall market ... acquisition offer valued at around 2 billion euros ($2.11 billion).
Evotec SE (EVT) Stock Price & News - Google Finance
Evotec Shares Surge on $2.11 Billion Buyout Offer · HALO. 14.10%. Halozyme Therapeutics, Inc. Yahoo Finance. 19 hours ago. Germany's Evotec Gets Takeover ...
Halozyme Reportedly Interested in Acquiring Evotec for $2.1 Billion
Halozyme Therapeutics, Inc. interested in acquiring Evotec SE for $2.1 Billion, Bloomberg said. Evotec is attracting potential takeover interest from ...
Recursion Pharmaceuticals secures stockholder nod for Exscientia ...
... million public offering of Class A common stock. The company has also secured support from Evotec SE for its proposed acquisition of UK ...
Europe's STOXX 600 falls as tech, healthcare shares drag - XM
Evotec jumps on 2 bln euro buyout offer from Halozyme. STOXX 600 down ... billion euros ($2.11 billion). Generali GASI.MI advanced 5.5 ...
Why NIO Shares Are Trading Lower By Over 8%? Here Are Other ...
The company will also offer warrants to purchase up to 1.425 million shares in a concurrent private placement. ... CNS Pharmaceuticals Prices Direct Offering; ...
CNS Pharmaceuticals Regains Compliance With Nasdaq Minimum ...
The company will also offer warrants to purchase up to 1.425 million shares in a concurrent private placement. The shares were priced at $1.39 each, while ...
ZAREBA SYSTEMS INC (Form: SC 13E3/A, Filing Date: 09/01/2009)
The Special Committee considered the feasibility of an issuer tender offer to repurchase the shares of common ... million, or $2.11 ... million shares outstanding ...
Camp Hill, Pennsylvania-based Rite Aid reported total drugstore sales of $2.21 billion for the month of December, up 4.9 percent from $2.11 billion in the ...